These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38023248)

  • 1. Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.
    Wu X; Xie W; Gong B; Fu B; Chen W; Zhou L; Luo L
    Front Oncol; 2023; 13():1162846. PubMed ID: 38023248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.
    Wu X; Xie W; Gong B; Fu B; Chen W; Zhou L; Luo L
    Front Oncol; 2023; 13():1124080. PubMed ID: 36776317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel oxidative stress-related genes signature associated with clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.
    Wu X; Li F; Xie W; Gong B; Fu B; Chen W; Zhou L; Luo L
    Front Oncol; 2023; 13():1184841. PubMed ID: 37601683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel amino acid metabolism-related gene signature to predict prognosis in clear cell renal cell carcinoma.
    Cheng X; Deng W; Zhang Z; Zeng Z; Liu Y; Zhou X; Zhang C; Wang G
    Front Genet; 2022; 13():982162. PubMed ID: 36118874
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma.
    Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X
    BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel 5 cuproptosis-related long noncoding RNA signature to predict diagnosis, prognosis, and drug therapy in clear cell renal cell carcinoma.
    Chen Y; Hu W; Wei X; Zhang L; Shao Y; Tian J; Wang D; Wu B
    Transl Androl Urol; 2023 Apr; 12(4):622-641. PubMed ID: 37181235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
    Hong Y; Lin M; Ou D; Huang Z; Shen P
    BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma.
    Wang K; Yu M; Zhang Z; Yin R; Chen Q; Zhao X; Yu H
    Transl Cancer Res; 2023 May; 12(5):1270-1289. PubMed ID: 37304554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
    Peng L; Liang J; Wang Q; Chen G
    Front Genet; 2022; 13():798846. PubMed ID: 35656315
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive analysis of LD-related genes signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Jia Y; Dong X; Yang F; Zhou L; Long H
    BMC Nephrol; 2024 Sep; 25(1):298. PubMed ID: 39256647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel immune-related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Jun; 36(6):e24409. PubMed ID: 35441741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 15. Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma.
    Wang B; Liu L; Wu J; Mao X; Fang Z; Chen Y; Li W
    Front Genet; 2022; 13():711142. PubMed ID: 35222525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma.
    Zhang L; Di L; Liu J; Lei X; Gu M; Zhang W; Wang Y
    Front Genet; 2023; 14():1039813. PubMed ID: 36755568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy.
    Lin J; Cai Y; Ma Y; Pan J; Wang Z; Zhang J; Liu Y; Zhao Z
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
    Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
    Front Genet; 2022; 13():1039465. PubMed ID: 36338978
    [No Abstract]   [Full Text] [Related]  

  • 20. Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction.
    Tai R; Leng J; Li W; Wu Y; Yang J
    BMC Urol; 2023 Sep; 23(1):147. PubMed ID: 37715154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.